Prolonged cross-bridge binding triggers muscle dysfunction in a fly model of myosin-based hypertrophic cardiomyopathy

  1. William A Kronert
  2. Kaylyn M Bell
  3. Meera C Viswanathan
  4. Girish C Melkani
  5. Adriana S Trujillo
  6. Alice Huang
  7. Anju Melkani
  8. Anthony Cammarato
  9. Douglas M Swank  Is a corresponding author
  10. Sanford I Bernstein  Is a corresponding author
  1. San Diego State University, United States
  2. Rensselaer Polytechnic Institute, United States
  3. Johns Hopkins University, United States

Abstract

K146N is a dominant mutation in human β-cardiac myosin heavy chain, which causes hypertrophic cardiomyopathy. We examined how Drosophila muscle responds to this mutation and integratively analyzed the biochemical, physiological and mechanical foundations of the disease. ATPase assays, actin motility, and indirect flight muscle mechanics suggest at least two rate constants of the cross-bridge cycle are altered by the mutation: increased myosin attachment to actin and decreased detachment, yielding prolonged binding. This increases isometric force generation, but also resistive force and work absorption during cyclical contractions, resulting in decreased work, power output, flight ability and degeneration of flight muscle sarcomere morphology. Consistent with prolonged cross-bridge binding serving as the mechanistic basis of the disease and with human phenotypes, 146N/+ hearts are hypercontractile with increased tension generation periods, decreased diastolic/systolic diameters and myofibrillar disarray. This suggests that screening mutated Drosophila hearts could rapidly identify hypertrophic cardiomyopathy alleles and treatments.

Data availability

Data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. William A Kronert

    Department of Biology, San Diego State University, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Kaylyn M Bell

    Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Meera C Viswanathan

    Department of Medicine, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Girish C Melkani

    Department of Biology, San Diego State University, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Adriana S Trujillo

    Department of Biology, San Diego State University, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Alice Huang

    Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Anju Melkani

    Department of Biology, San Diego State University, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Anthony Cammarato

    Department of Medicine, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Douglas M Swank

    Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, United States
    For correspondence
    swankd@rpi.edu
    Competing interests
    The authors declare that no competing interests exist.
  10. Sanford I Bernstein

    Department of Biology, San Diego State University, San Diego, United States
    For correspondence
    sbernstein@sdsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7094-5390

Funding

National Institutes of Health (R37GM032443)

  • Sanford I Bernstein

National Institutes of Health (R01HL124091)

  • Anthony Cammarato

National Institutes of Health (R01AR064274)

  • Douglas M Swank

Rees-Steely Research Foundation (Graduate Student Fellowship)

  • Adriana S Trujillo

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Copyright

© 2018, Kronert et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,245
    views
  • 259
    downloads
  • 29
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. William A Kronert
  2. Kaylyn M Bell
  3. Meera C Viswanathan
  4. Girish C Melkani
  5. Adriana S Trujillo
  6. Alice Huang
  7. Anju Melkani
  8. Anthony Cammarato
  9. Douglas M Swank
  10. Sanford I Bernstein
(2018)
Prolonged cross-bridge binding triggers muscle dysfunction in a fly model of myosin-based hypertrophic cardiomyopathy
eLife 7:e38064.
https://doi.org/10.7554/eLife.38064

Share this article

https://doi.org/10.7554/eLife.38064

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Róża K Przanowska, Yuechuan Chen ... Anindya Dutta
    Research Article

    The six-subunit ORC is essential for the initiation of DNA replication in eukaryotes. Cancer cell lines in culture can survive and replicate DNA replication after genetic inactivation of individual ORC subunits, ORC1, ORC2, or ORC5. In primary cells, ORC1 was dispensable in the mouse liver for endo-reduplication, but this could be explained by the ORC1 homolog, CDC6, substituting for ORC1 to restore functional ORC. Here, we have created mice with a conditional deletion of ORC2, which does not have a homolog. Although mouse embryo fibroblasts require ORC2 for proliferation, mouse hepatocytes synthesize DNA in cell culture and endo-reduplicate in vivo without ORC2. Mouse livers endo-reduplicate after simultaneous deletion of ORC1 and ORC2 both during normal development and after partial hepatectomy. Since endo-reduplication initiates DNA synthesis like normal S phase replication these results unequivocally indicate that primary cells, like cancer cell lines, can load MCM2-7 and initiate replication without ORC.

    1. Cell Biology
    2. Developmental Biology
    Pavan K Nayak, Arul Subramanian, Thomas F Schilling
    Research Article Updated

    Mechanical forces play a critical role in tendon development and function, influencing cell behavior through mechanotransduction signaling pathways and subsequent extracellular matrix (ECM) remodeling. Here, we investigate the molecular mechanisms by which tenocytes in developing zebrafish embryos respond to muscle contraction forces during the onset of swimming and cranial muscle activity. Using genome-wide bulk RNA sequencing of FAC-sorted tenocytes we identify novel tenocyte markers and genes involved in tendon mechanotransduction. Embryonic tendons show dramatic changes in expression of matrix remodeling associated 5b (mxra5b), matrilin 1 (matn1), and the transcription factor kruppel-like factor 2a (klf2a), as muscles start to contract. Using embryos paralyzed either by loss of muscle contractility or neuromuscular stimulation we confirm that muscle contractile forces influence the spatial and temporal expression patterns of all three genes. Quantification of these gene expression changes across tenocytes at multiple tendon entheses and myotendinous junctions reveals that their responses depend on force intensity, duration, and tissue stiffness. These force-dependent feedback mechanisms in tendons, particularly in the ECM, have important implications for improved treatments of tendon injuries and atrophy.